Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.21 EUR | +0.65% | -4.61% | -6.48% |
May. 22 | Nanobiotix: strategy update, share price declines | CF |
May. 21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
Official Publications
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Official Publications